ER-alpha promoter methylation is a specific biomarker for outcome prediction of cisplatin resistant

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:ccwawa
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: An increasing number of studies have suggested that the link between ERα methylation and triple-negative breast cancer (TNBC).We previously found the ERα methylation status in basal-like breast cancer was significantly higher than that in sporadic non-basal-like breast cancer.
其他文献
  Objective: To evaluate the potential utility of circulating tumor cells (CTCs) measurements in predicting prognosis of hepatocellular carcinoma (HCC) patien
会议
  Objective: The purpose was to compare folinic acid, 5-fluorouracil (5-FU), and irinotecan (mFOLFIRI;arm A) with folinic acid, 5-FU, and oxaliplatin (mFOLFOX
会议
  Objective: Whether adjuvant chemoradiotherapy (ACRT) or chemotherapy (ACT) will benefit for stage Ⅱ or Ⅲ upper rectal cancer (URC) after radical surgery r
会议
  Objective: The aim of the study is to evaluate the safety and feasibility of laparoscopic abdominal peritoneal resection (LAPR) for rectal cancer compared w
会议
  目的:探讨富含半胱氨酸的分泌性酸性蛋白(SPARC)在三阴性乳腺癌(TNBC)肿瘤组织的表达及其与预后的相关性。方法:收集2004年至2008年在我院行乳腺癌手术的211例三阴性乳腺癌
  Objective: Proposed a new IMRT treatment planning technique with the potential of reducing low dose region of the lungs in esophageal cancer patients treate
会议
  目的:探讨循环血肿瘤细胞在晚期乳腺癌患者中阳性率,及其与患者一般情况、治疗情况及生存关系。方法:选择2013年1月至2013年10月在我院正在治疗的晚期乳腺癌患者41例,抽取
  目的:剂量密集化疗方案相对常规3周方案能提高乳腺癌辅助化疗患者的生存,而在新辅助化疗方面研究较少。因此,我们进行了一项Ⅱ期的临床研究,探讨紫杉醇联合卡铂加或不加曲妥
  目的:对即刻淋巴静脉吻合预防上肢淋巴水肿进行初步临床应用,探索术中在显微镜近红外光成像系统下应用吲哚菁绿淋巴造影,研究其淋巴管显像情况,协助淋巴管断端定位。方法:对20
  目的:探讨循环肿瘤细胞(circulating tumor cells,CTC)检测在转移性乳腺癌(metastatic breast cancer,MBC)化疗疗效评价中的应用价值。方法:共入组136例MBC患者,每3个化疗